Intratumoral CAN1012(selective TLR7 Agonist) in Subjects with Solid Tumors
Intratumoral CAN1012(selective TLR7 Agonist) in Subjects with Solid Tumors
Active, not recruiting · NCT05580991 · Registry updated 2025-02-13Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Intratumoral CAN1012(selective TLR7 Agonist) in Subjects with Solid Tumors | Solid Tumor | Active, not recruiting | Phase 1 | 2025-02-13 | NCT05580991 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Canwell Biotech Limited | 3 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Canwell Biotech Limited | Guangzhou | China | 1 |